Quintuple agonists herald a new era in obesity care, unlocking the potential for powerful, sustained weight loss and improved ...
News Medical on MSN
The future of obesity management – quintuple and other super polyagonists for weight loss and maintenance?
Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...
In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with ...
News-Medical.Net on MSN
Gut probiotic Christensenella tenuis reduces endotoxemia and improves metabolism in obese mice
This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that the gut ...
News-Medical.Net on MSN
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
Researchers used drug-target Mendelian randomization to test whether genetically proxied activation of GLP1R and GIPR ...
This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that the gut probiotic Christensenella ...
USBC shifts from med-tech to fintech, focusing on a dollar-backed stablecoin and Bitcoin treasury. Click here to find out why ...
In an industry where transparency remains the exception rather than the norm, Herba Health Inc. has turned bold transparency ...
Preclinical experiments and an ongoing phase 1 trial suggest that RES-010 may complement and enhance the efficacy of ...
WHO has added obesity and diabetes drugs such as Wegovy and Zepbound to the essential medicines list in a bid to boost global accessibility.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback